ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

MREO Mereo BioPharma Group PLC

2.74
-0.07 (-2.49%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Mereo BioPharma Group PLC MREO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.07 -2.49% 2.74 06:32:57
개장가 저가 고가 종가 전일 종가
2.81 2.73 2.81 2.74 2.81
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/04/202420:30GLOBEMereo BioPharma to Participate in Fireside Chat at the 23rd..
28/03/202405:01GLOBEMereo BioPharma Reports Full Year 2023 Financial Results and..
05/03/202421:30GLOBEMereo BioPharma to Participate in Fireside Chat at the..
10/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202406:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202406:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/01/202421:08EDGAR2Form 8-K - Current report
08/01/202421:00GLOBEMereo BioPharma Provides Update on Pipeline Progress and..
03/01/202406:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202406:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202406:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202406:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202406:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202406:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202406:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/12/202306:16EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
19/12/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/202306:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202321:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202305:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202305:01GLOBEMereo BioPharma Reports on Recent Program Developments and..
17/10/202320:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/10/202305:30GLOBEUltragenyx and Mereo BioPharma Announce Interim Phase 2 Data..
09/10/202321:00GLOBEUltragenyx to Present Setrusumab (UX143) Update at ASBMR..
21/09/202320:00GLOBEMereo BioPharma to Participate in Fireside Chat at the 2023..
21/09/202305:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/09/202320:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/09/202320:30GLOBEMereo BioPharma Reports Interim Financial Results for the..
27/07/202305:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/07/202321:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/07/202321:00GLOBEUltragenyx Announces First Patients Dosed in Phase 3 Program..
01/07/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/05/202320:00GLOBEMereo BioPharma to Present at the Jefferies Healthcare..
24/05/202302:43GLOBEPhase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s..
09/05/202301:46GLOBEMereo BioPharma Regains Compliance with Nasdaq Minimum Bid..
06/05/202305:06GLOBEMereo BioPharma Announces Listing Transfer to Nasdaq Capital..

최근 히스토리

Delayed Upgrade Clock